Popular Articles
Cellulite Cream

Rolofylline Did Not Demonstrate Efficacy For Acute Heart Failure In Clinical Trial
Merck & Co., Inc. said that preliminary results for the pivotal Phase III study of rolofylline (MK-7418), the Company"s investigational medicine for the treatment of acute heart failure, show that rolofylline did not meet the primary or secondary efficacy endpoints. While Merck will continue to analyze the data with outside experts, the Company will not file applications for regulatory approval this year. The results from this study will be presented at a medical meeting later this year.
generic viagra online
Larger Hospital Units Have Lower Miscarriage Rates After Invasive Pregnancy Tests
A study of more than 64,000 pregnant women has found that miscarriage rates
News of the day
Women More Susceptible To Harmful Effects Of Smoking
Women may be more susceptible to the lung damaging effects of smoking than men, according to new research by Inga-Cecilie Soerheim, M.D., and her colleagues from Channing Laboratory, Brigham and Women"s Hospital and University of Bergen, Norway.
Health Insurance

Public Equipped To Fight Back Against Hospital Bugs As Ward Closure Numbers Soar, UK

A British company has launched an anti-infection kit specifically designed to protect hospital patients and visitors from MRSA, Norovirus, Swine-flu, E-Coli and other hospital-acquired infections. The PatientGuard kit includes the world"s first dry-on-contact spray suitable for use on hospital bed linen, curtains and other "near patient touch sites." The launch coincides with the release of new figures on ward closures due to Norovirus from the Health Protection Agency, which show a 23 per cent increase on the same period last year. Jim Taylor,a former President of Healthcare giant Smith & Nephew and now CEO of Saniguard International, the company behind the kit, believes its launch is timely. "An ICM Poll for the BBC in 2008 showed that 30% of people would consider delaying or avoiding surgery because they fear contracting a hospital acquired infection (HAI). PatientGuard is designed to give people the power to protect themselves when they need hospital treatment." The launch of PatientGuard also coincides with a British Medical Association report criticising Government policy with regard to cleaning regimes in hospitals, where the focus is on deep cleans and the use of alcohol-based hand gels rather than regular disinfection of near patient touch sites. Saniguard International


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):